Canada markets close in 5 hours 7 minutes

Lexaria Bioscience Corp. (LXRP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1972+0.0029 (+1.47%)
At close: 3:40PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 517.75M
Enterprise Value 316.3M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)46.16
Price/Book (mrq)7.04
Enterprise Value/Revenue 342.38
Enterprise Value/EBITDA 6-4.35

Trading Information

Stock Price History

Beta (5Y Monthly) 2.24
52-Week Change 3-55.56%
S&P500 52-Week Change 315.56%
52 Week High 30.5700
52 Week Low 30.1700
50-Day Moving Average 30.2022
200-Day Moving Average 30.2813

Share Statistics

Avg Vol (3 month) 3233.22k
Avg Vol (10 day) 3257.76k
Shares Outstanding 589.59M
Float 67.5M
% Held by Insiders 10.60%
% Held by Institutions 10.11%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 211:10
Last Split Date 3Dec. 15, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug. 30, 2020
Most Recent Quarter (mrq)Aug. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,004.37%

Management Effectiveness

Return on Assets (ttm)-87.72%
Return on Equity (ttm)-164.27%

Income Statement

Revenue (ttm)384.54k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)6.90%
Gross Profit (ttm)276.93k
EBITDA -3.75M
Net Income Avi to Common (ttm)-3.93M
Diluted EPS (ttm)-0.0470
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.31M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)156.1k
Total Debt/Equity (mrq)6.29
Current Ratio (mrq)8.52
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-2.66M
Levered Free Cash Flow (ttm)-1.03M